scientific
strategic
plan
global
vaccine
enterprise
published
month
plo
medicine
clear
cogent
document
describing
major
funders
stakeholder
hiv
vaccine
development
move
forward
collaborative
fashion
doubt
roadmap
regarded
useful
instrument
bring
greater
cohesion
coordination
field
individual
championed
effort
commended
providing
great
service
scientific
community
excellent
start
continuing
dialogue
utmost
importance
challenge
still
protective
vaccine
hiv
year
initial
identification
many
possible
explanation
come
mind
natural
course
hiv
infection
virus
win
time
showing
specific
immunity
infected
person
unable
completely
clear
virus
also
known
decade
primary
hiv
isolates
relatively
resistant
antibody
neutralization
probably
protective
shield
viral
envelope
glycoprotein
consisting
variable
loop
sequence
extensive
glycosylations
another
explanation
extreme
plasticity
hiv
allows
new
viral
variant
evade
immune
recognition
way
escape
drug
moreover
superinfection
second
viral
strain
documented
number
individual
already
mounted
immune
response
initial
hiv
infection
yet
another
problem
aid
research
community
yet
uncover
correlate
immune
protection
vivo
lastly
proven
vaccine
approach
past
either
failed
whole
killed
virus
subunit
vaccine
faced
seemingly
insurmountable
regulatory
hurdle
live
attenuated
virus
vaccine
given
daunting
obstacle
many
continued
long
struggle
develop
hiv
vaccine
answer
must
lie
part
noble
hand
yet
also
encouraging
clinical
experimental
observation
figure
rare
patient
control
hiv
infection
spontaneously
certain
people
remain
despite
repeated
exposure
superinfection
commonly
found
support
notion
immune
control
protection
simian
immunodeficiency
virus
indeed
possible
using
live
virus
attenuated
specific
mutation
pharmacological
intervention
finally
perhaps
importantly
hiv
transmission
sex
natural
setting
typically
inefficient
thus
easier
block
unlike
experimental
challenge
system
employed
monkey
study
date
collectively
finding
provide
ray
hope
push
enterprise
scientific
strategic
plan
enterprise
identifying
major
roadblock
hiv
vaccine
development
well
establishing
key
scientific
priority
see
today
rightly
recommends
formation
growing
alliance
organization
foster
better
collaborative
spirit
could
lead
among
thing
stronger
political
support
increased
funding
proposed
greater
coordination
management
sharing
information
technology
reagent
harmonization
standard
assay
approach
could
add
overall
effort
one
might
ask
however
whether
potential
downside
plan
name
continuing
important
dialogue
would
like
offer
one
general
concern
arguably
reason
lack
effective
hiv
vaccine
today
rooted
basic
problem
posed
virus
need
foremost
new
scientific
solution
although
prim
proper
process
structure
approach
helpful
needed
breakthrough
develop
vaccine
likely
emerge
creativity
scientist
fundamental
research
free
preconceived
bias
contention
great
new
idea
likely
come
basic
study
approach
represented
new
proposal
therefore
leadership
enterprise
must
safeguard
kind
group
think
pervasive
large
collaborative
endeavor
nature
view
small
number
researcher
matter
smart
accomplished
must
supersede
collective
wisdom
scientific
community
large
doubt
important
contribution
made
scientist
working
outside
enterprise
measure
taken
ensure
view
approach
even
deemed
unconventional
stifled
newly
established
system
likewise
research
support
compromised
creation
enterprise
concentrate
funding
hand
relatively
small
number
designated
scientist
serious
risk
given
current
flat
funding
national
institute
health
future
author
global
vaccine
enterprise
scientific
strategic
plan
laid
timely
insightful
plan
address
perhaps
greatest
need
millennium
document
later
revision
serve
useful
guidepost
aid
vaccine
development
effort
year
come
successful
mission
research
community
ultimately
need
specific
scientific
blueprint
making
hiv
vaccine
day
come
get
another
shot
arm
infusing
new
knowledge
doubt
need
redouble
investment
basic
research
challenge
posed
hiv